FEATURED ARTICLES
My SCOPE Groundhog Day Experience
From feasibility inefficiencies to overdesigned trials and overloaded investigative sites, the conversations at SCOPE were thoughtful and candid. The problem isn’t ignorance. It’s execution. Until simplification shows up in shorter timelines, leaner protocols, and measurable relief for sites, we may continue gathering each year to discuss the same issues — with the same data.
-
Becoming A Backbone Therapy: Lessons Learned With Actuate Therapeutics
CEO Dan Schmitt discusses the pursuit of a backbone therapy and how Actuate's current and planned trials are structured to confirm that potential.
-
Why Dr. Robert Califf Isn't Pulling His Punches Anymore
In this exclusive video interview, former FDA commissioner Robert Califf, MD reflects on quality, risk aversion, misinformation, and why clinical trials need sharper focus — not more data.
-
Choosing Clinical Research … On Purpose
Most clinical research careers begin by accident. Rutgers University is trying to change that with formal training programs designed for today’s academic and industry trial environments. Barbara Tafuto, Ph.D., interim program director of the Master’s in Clinical Research Management program at Rutgers University, explains the program’s genesis and potential impact on the industry.